Cervical cancer screening

1. Cervical cancer screening decreases mortality in humans (ASR AAPC: -2.5%; 95% CI: -2.8 to -2.2).

   Humansfollowing the scale-up of its organized national screening programmefemales

   Global Trends and Disparities in Cervical Cancer Control in Central Asia (1990-2023): A Comparative Age-Period-Cohort and Joinpoint Regression Analysis · Asian Pacific journal of cancer prevention : APJCP · 1 Sep 2026

1. Cervical cancer screening lowers the risk of cervical cancer in silico (~387K cases averted).

   “Scaling up screening to WHO targets was estimated to avert a further ~387K cases (IQR 331-424K; 95% UI 269-515K), roughly 25% of the residual burden”

   In silicoWHO targets scale-up (70% aggregate)2025-2100

   Model-based evaluation of an infant HPV prophylactic vaccination program in Nigeria · medRxiv · 2 Oct 2026 · Preprint

Cervical cancer →